Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate Thalidomide for treatment of disseminated MALT Lymphoma or at relapse following helicobacter pylori (HP) - eradication or chemotherapy or radiation.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Vienna
NCT06228963 · MALT Lymphoma of Stomach, Helicobacter Pylori Infection
NCT01808599 · MALT Lymphoma
NCT07376330 · MALT Lymphoma
NCT00783367 · Follicular Lymphoma, Marginal Zone B-Cell Lymphoma, and more
NCT05003141 · Follicular Lymphoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, and more
Department of Internal Medicine I
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions